| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/17/1994 | CA2141332A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 02/17/1994 | CA2141210A1 Novel piperazine carboxamides |
| 02/17/1994 | CA2141051A1 Substituted nitrogen-containing heterocycles |
| 02/17/1994 | CA2140883A1 Asymmetrically substituted xanthines |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2140008A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2125477A1 Therapeutic methods using caesium ions |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0508995B1 Muscarinic receptor antagonists |
| 02/16/1994 | EP0409931B1 Quinuclidine therapeutic agents |
| 02/16/1994 | CN1082044A 吲哚衍生物 Indole derivatives |
| 02/16/1994 | CN1082040A 吲哚类 Indoles |
| 02/16/1994 | CN1082039A Indoles |
| 02/15/1994 | US5286753 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and pharmaceutical compositions thereof |
| 02/15/1994 | US5286735 Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics |
| 02/15/1994 | US5286732 Nitrogen-containing bicyclic compounds and pharmaceutical compositions thereof |
| 02/15/1994 | US5286252 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
| 02/15/1994 | CA2101417A1 Prophylactic and therapeutic treatment of alzheimer's disease |
| 02/15/1994 | CA1327011C Pharmaceutical compositions for piperidino alkanol-ibuprofen combination |
| 02/15/1994 | CA1327008C Anti-psychotic imidazobenzodiazepine |
| 02/15/1994 | CA1327003C Pharmacological use of uridine in the treatment of nervous disorders |
| 02/12/1994 | CA2103601A1 1,4-benzodioxane derivatives |
| 02/09/1994 | EP0582506A1 Tetrahydronaphtalene derivatives, their preparation and their application in therapy |
| 02/09/1994 | EP0582368A1 Thienobenzodiazepine derivatives for treatment of CNS disorders |
| 02/09/1994 | EP0582330A1 Use of polysaccharides for treating acute peripheral neuropathies |
| 02/09/1994 | EP0582186A1 Process for producing solid pharmaceutical dosage forms with an extended two-stage release |
| 02/09/1994 | EP0582182A1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions |
| 02/09/1994 | EP0582164A1 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 02/09/1994 | EP0581907A1 Inhibitors of kynureninase |
| 02/09/1994 | EP0581865A1 Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins |
| 02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 02/09/1994 | EP0581849A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 02/09/1994 | EP0581797A1 Novel thiophene-2-carboxylic acid derivatives and process for their production. |
| 02/09/1994 | EP0581777A1 Stereoselective preparation of substituted piperidines |
| 02/09/1994 | CN1081679A Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation |
| 02/09/1994 | CN1081669A Compounds for the treatment of nemodegenerative disorders |
| 02/08/1994 | US5284957 Substituted 1H- or 2H-tetrazoles |
| 02/08/1994 | US5284861 Blended with deprenyl and biperiden; muscle relaxant |
| 02/08/1994 | US5284859 Analgesics, Alzheimer's disease |
| 02/08/1994 | US5284847 Neurological and psychological disorders; antagonist at the glycine binding site on the N-methyl-D-aspartate receptor complex |
| 02/08/1994 | US5284843 Pharmacological treatment of ocular development |
| 02/08/1994 | US5284839 Neuropeptide antagonist; renal and cerebral areas included |
| 02/08/1994 | US5284664 Administering mammalian liver extract |
| 02/06/1994 | CA2101915A1 Tetrahydronaphthalene derivatives, their preparation and their application in therapy |
| 02/03/1994 | WO1994002623A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | WO1994002596A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 02/03/1994 | WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 02/03/1994 | WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES |
| 02/03/1994 | WO1994002482A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/03/1994 | WO1994002477A1 Imidazole, triazole and tetrazole derivatives |
| 02/03/1994 | WO1994002475A1 Drugs that enhance synaptic responses mediated by ampa receptors |
| 02/03/1994 | WO1994002473A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 02/03/1994 | WO1994002462A1 4-amino-n^_-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 02/03/1994 | WO1994002461A1 Azacyclic compounds |
| 02/03/1994 | WO1994002460A1 Indol derivatives for the treatment of migraine |
| 02/03/1994 | WO1994002166A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | WO1994002147A1 Water-dispersible tablets |
| 02/03/1994 | DE4218292C1 Verwendung eines Arzneimittels mit einem Gehalt an Mestanolon und/oder 4-Chlor-1-dehydromethyltestosteron Use of a pharmaceutical having a content of mestanolone and / or 4-chloro-1-dehydromethyltestosteron |
| 02/03/1994 | CA2140924A1 Bis-staurosporine and k-252a derivatives |
| 02/03/1994 | CA2140760A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | CA2140241A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | CA2140229A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 02/03/1994 | CA2138650A1 Azacyclic compounds |
| 02/03/1994 | CA2138649A1 Imidazole, triazole and tetrazole derivatives |
| 02/03/1994 | CA2136837A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/02/1994 | EP0581677A1 Cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 02/02/1994 | EP0581457A1 Use of cytisine compounds for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 02/02/1994 | EP0581456A1 Use of phenylpyrrolidines for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 02/02/1994 | EP0581107A1 Method of preparation of physostigmine carbamate derivatives from eseretholes |
| 02/02/1994 | EP0581106A1 Substituted aminothienopyridines, a process for their preparation and their use as medicaments |
| 02/02/1994 | EP0581062A1 Use of 1,2,5-oxadiazole-2-oxides for the manufacture of a medicament for the treatment of erectile dysfunctions |
| 02/02/1994 | EP0580776A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
| 02/02/1994 | EP0580658A1 Nabumetone powders |
| 02/02/1994 | EP0580644A1 1,3,4-trisubstituted piperidine derivatives, their production and use. |
| 02/02/1994 | EP0528968B1 (3-alkylthio propyl)-3 benzothiazoline derivatives, preparation thereof and drugs containing said derivatives |
| 02/01/1994 | US5283240 Administering prostaglandin antagonists |
| 02/01/1994 | CA2101311A1 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 02/01/1994 | CA2100197A1 Use of polysaccharides in acute peripheral neuropathies |
| 02/01/1994 | CA1326680C N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
| 02/01/1994 | CA1326670C Fused 2,3-dihydroxypyrazines their preparation and use |
| 01/31/1994 | CA2101581A1 1-aminoacetamidopyrroles and 1-amino acetamido-2-(substituted) pyrroles and related compounds |
| 01/26/1994 | EP0580539A2 Amidines derived from 3-aminoethyl indoles for the treatment of migraines |
| 01/26/1994 | EP0580503A1 Aminoalkylchromones, process for their preparation and compositions containing them |
| 01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580429A1 Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
| 01/26/1994 | EP0579819A1 Novel pyridone derivatives, preparation method therefor, novel intermediates thereby obtained, their use as drugs, and pharmaceutical compositions containing same |
| 01/26/1994 | EP0579681A1 Crystalline tiagabine hydrochloride monohydrate, its preparation and use |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579615A1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments |
| 01/26/1994 | EP0500658B1 A nicotine containing stimulant unit |
| 01/26/1994 | EP0497906B1 L-alpha-glycerophosphoryl-d-myo-inositol for the treatment of peripheral neuropathies and of cerebropathies |
| 01/26/1994 | CN1023602C Antipsychotic 3-piperazinylbenzazole derivants |
| 01/26/1994 | CN1023599C Process for preparing chloroaniline derivate |
| 01/25/1994 | US5281722 Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
| 01/25/1994 | US5281711 (S)-1-[10-chloro-6,7-dihydro-4-oxo-3-phenyl-4H-benzo[a]quino-lizin-1-yl)carbonyl]-3-ethoxypyrrolidine |
| 01/25/1994 | US5281624 Neurological disorders associated with norepinephrine imbalance |
| 01/25/1994 | US5281614 Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists |
| 01/25/1994 | US5281606 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 01/25/1994 | US5281598 Piperazine derivatives |